Curevac
CVAC | F
Overview
Corporate Details
- ISIN(s):
- NL0015436031
- LEI:
- 724500BUT8GAG9LMYN56
- Country:
- Germany
- Address:
- Friedrich-Miescher-Strasse 15, 72076 Tübingen
- Website:
- https://www.curevac.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 02:15 |
Legal Proceedings Report
CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech
|
English | 11.5 KB | |
| 2025-06-24 22:09 |
Declaration of Voting Results & Voting Rights Announcements
CureVac Announces Voting Results of General Meeting
|
English | 10.0 KB | |
| 2025-05-20 13:00 |
Earnings Release
CureVac Announces Financial Results for the First Quarter of 2025 and Provides …
|
English | 23.3 KB | |
| 2025-05-15 22:10 |
Legal Proceedings Report
CureVac Receives Additional Positive Validity Decision from European Patent Off…
|
English | 12.1 KB | |
| 2025-04-10 13:12 |
Earnings Release
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 a…
|
English | 39.8 KB | |
| 2025-04-09 13:00 |
Report Publication Announcement
CureVac to Report Fourth Quarter and Full-Year 2024 Financial Results and Busin…
|
English | 10.4 KB | |
| 2025-04-07 13:00 |
Regulatory News Service
CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for …
|
English | 14.7 KB | |
| 2025-03-27 21:05 |
Legal Proceedings Report
CureVac Receives Positive Validity Decision from European Patent Office in Liti…
|
English | 11.9 KB | |
| 2025-02-19 13:03 |
Environmental & Social Information
CureVac Earns Repeat Recognition by LexisNexis as One of the Worlds Top Innovat…
|
English | 12.2 KB | |
| 2025-02-18 13:03 |
Regulatory News Service
CureVac Earns Repeat Recognition by LexisNexis as One of the Worlds Top Innovat…
|
English | 12.2 KB | |
| 2024-04-25 00:00 |
Annual Report
|
English | 4.3 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Theradiag | France | ALTER | |
|
Theranexus | France | ALTHX | |
|
Thor Medical ASA | Norway | NANOV | |
|
TME Pharma N.V. | Germany | ALTME | |
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
| Uni-Bio Science Group Ltd | Hong Kong | N/A | ||
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M |